Non-MHC-restricted cytotoxic cells: their roles in the control and treatment of leukaemias.
Lowdell
M W
MW
Department of Haematology -- RF-Campus, Royal Free & University College Medical School, London, UK. m.lowdell@rfc.ucl.ac.uk
Lamb
L
L
Hoyle
C
C
Velardi
A
A
Prentice
H G
HG
D000818:Animals; D006086:Graft vs Host Disease; D020544:Graft vs Leukemia Effect; D006648:Histocompatibility; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D008213:Lymphocyte Activation; D008222:Lymphokines / Q000276:immunology; D051379:Mice; D018345:Mice, Knockout; D023421:Models, Animal; D016032:Randomized Controlled Trials as Topic; D016692:Receptors, Antigen, T-Cell, gamma-delta; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000502:physiology*; D014184:Transplantation, Homologous
D008222:Lymphokines; D016692:Receptors, Antigen, T-Cell, gamma-delta